Director Polinsky David 🟢 acquired 5.1K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041133
Director Wexler William A. 🟢 acquired 5.9K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041132
Director Ratner Elena 🟢 acquired 5.9K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041131
Director Luther Sanjeev 🟢 acquired 118.8K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041130
Director Carter Denise P. 🟢 acquired 30.7K shares (1 derivative) of Quoin Pharmaceuticals, Ltd. (QNRX) at $6.10 Transaction Date: Aug 31, 2026 | Filing ID: 104405
Director Myers Michael 🟢 acquired 30.7K shares (1 derivative) of Quoin Pharmaceuticals, Ltd. (QNRX) at $6.10 Transaction Date: Aug 31, 2026 | Filing ID: 104404
📋 IFC African, Latin American and Caribbean Fund, LP (May be deemed affiliate) plans to sell 857K shares of LESAKA TECHNOLOGIES INC (at $4.56 each, total $3.9M) Filed: Sep 02, 2026 | ID: 000856